FlowMetric launches breakthrough COVID-19 antibody test


Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /home/medicircle/public_html/script_newsdetails.php on line 75
▴ FlowMetric launches breakthrough COVID-19 antibody test
FlowMetric introduces a powerful advancement in COVID-19 antibody testing that delivers exceptional performance compared to existing tests on the global market today, including the ELISA gold standard.

Accurate and sensitive testing to determine the presence of COVID-19 antibodies is essential for the development of safe and effective vaccines and therapeutics targeting the COVID-19 virus. Until now, the ELISA platform has been the gold standard for antibody testing, despite its limitations.

FlowMetric Life Sciences, using their expertise in immune response and in the powerful Flow Cytometry technology platform, have created and brought to market recently an innovative COVID-19 antibody test that delivers:

> 99% specificity and > 99% sensitivity (> 14 days post COVID-19 symptoms)
Ability to differentiate an infection due to virus exposure vs. a vaccine response
Detection of antibodies over a wide dynamic range
Simultaneous identification of antibodies to multiple SARS-CoV-2 (COVID-19) proteins
Double the amount of information over the same testing time period vs. ELISA platform

"The applications of this advanced, multiplexed assay are ideal for companies working on vaccine development or COVID-19 related therapeutics," said Renold J. Capocasale, Founder and CEO of FlowMetric.

Compared with other existing antibody tests, FlowMetric's breakthrough antibody test delivers the ability to differentiate an infection due to virus exposure vs. a vaccine response, identify simultaneous detection of viral antibodies, rapid turn-around times, and excellent sensitivity and exceptional specificity on a proven, high-throughput flow cytometry platform.

The novel antibody test is offered at FlowMetric's CLIA-certified, High Complexity laboratory. FlowMetric can process over 1,000 samples per day with results provided in 24-48 hours.

Tags : #FlowMetric #LatestNewsonFlowMetric5thDec #LatestPharmaNews5thDec #LatestNewsonCOVIDTest5thDec #ELISAGoldStandard #FlowCytometryTechnology

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026
Tuberculosis Contact Screening: How Preventive Care Works Around ExposureNovember 13, 2026
COPD Care in India: Linking Diagnosis, Inhaler Education and Follow-UpNovember 13, 2026
Management of ANCA Glomerulonephritis: Induction & Maintenance ProtocolsNovember 12, 2026
Smart Hospital Command Centres Transforming IndiaNovember 12, 2026
Gamma Knife Surgery in India: What You Need to KnowNovember 12, 2026